Development of ALL-Hematotox: predicting post-CAR T-cell hematotoxicity in B-cell acute lymphoblastic leukemiaMonica Nair, Nirali N. Shah, Rebecca Gardner et al.|Blood|2024Cited by 23
Real-world outcomes for young adult patients receiving CD19 CAR T-cell therapyHannah Lust, Rawan Faramand, Liora M. Schultz et al.|Blood Advances|2025Cited by 15
International consensus guidelines for the conduct and reporting of CAR T-cell clinical trials in AMLSwati Naik, Saar Gill, Richard Aplenc et al.|Blood Advances|2025Cited by 7
CAR HEMATOTOX independently predicts outcomes after CD19 CAR-T therapy for acute lymphoblastic leukemiaYannis K. Valtis, Jae H. Park, Chenyu Lin et al.|Blood Advances|2025Cited by 3
Liberalizing hospital proximity requirements for children/young adults with low-burden B-ALL receiving tisagenlecleucelLauren Appell, Christina Baggott, Khanh Nguyen et al.|Blood Advances|2025Cited by 0